Transcript β-Lactam Antibiotics
Antibiotic Overview
Nathan P. Samsa, Pharm.D., R.Ph.
1
Objectives
• Briefly discuss pharmacokinetics • Review basic pharmacology of the various antibiotics • Address indications and side effects • Provide helpful mnemonics • Correlate infectious diseases with appropriate pharmacological therapy 2
“Basic” Pharmacokinetics
• “ADME” – Adsorption – Distribution – Metabolism – Excretion • Pharmacokinetics: – “How the body acts on the drug” • Pharmacodynamics: – “How the drug acts on the body” 3
How Can We Inhibit Bacteria?
• Bacteristatic – Inhibits a vital pathway used in the growth of the bacteria, but does not directly cause death • Bactericidal – Disrupts bacterial function so much that death will occur 4
What Manner Can We Kill?
• Time-dependent – Drug concentration must remain constantly above the minimum inhibitory concentration (MIC) • β-lactams, vancomycin • Concentration-dependent – Drug concentration must reach a certain concentration, many times based on the area under the curve (AUC) • Fluoroquinolones 5
What Can We Disrupt?
• Cell Wall • Folic Acid Synthesis • Nucleic Acid Synthesis • Ribosome • Cell Membrane 6
Cell Wall Inhibitors
7
Cell Wall Agents
• β-Lactams – Penicillins – Cephalosporins – Monbactams – Carbapenems • Glycopeptides 8
β-Lactams
• Bacterial cell walls have 5-peptide chains (
L
-ala—
D
-glu—
L
-lys—
D
-ala—
D
-ala) cross linked by penicillin binding proteins (PBP) • The β-lactam ring system looks like
D
ala—
D
-ala, where the PBPs will use the β lactam instead • The β-lactam “pops open,” destroying the PBP and halting further crosslinking cell wall weakens lysis 9
β-Lactam Subtypes
• All share a β-lactam ring, thereby having the same mechansim of action (and explaining the cross-sensitivity between classes) – Penicillins – Cephalosporins – Monobactams – Carbapenems 10
Penicillin Classifications
• Narrow-spectrum penicillins • Penicillinase-resistant penicillins • Extended-spectrum penicillins 11
Narrow-Spectrum Penicillins
• Penicillin G (Pfzierpen • Penicillin V (Pen-Vee K ® ® )-IM, IV, PO – More active against Neiserra and anaerobes , Veetids ® )-PO – Keep it straight: V is not IV • Good activity against Gram {+} cocci • Anaerobic activity (except Bacteroides) • Drug of choice for syphilis, gas gangrene, and meningococcus • No activity against aerobic Gram {-} 12
Penicillinase-Resistant Agents
• Cloxacillin (Cloxapen ® ) • Dicloxacillin (Dynapen ® ) • Methacillin (Staphcillin ® ) – Discontinued in US • Nafcillin (Nafcil ® ) • Oxacillin (Prostaphlin ® ) 13
Penicillinase-Resistant PCNs
• Originally designed solely for coverage against S. aureus (methicillin-susceptable S. aureus [MSSA]) • Decreased activity against other bugs • S. aureus becoming increasingly resistant to this class (MRSA), as well as
Staphylococcus epidermidis
– Vancomycin treatment of choice for MRSA • Eliminated hepatically 14
Extended-spectrum PCNs
• Aminopenicillins • Carboxypenicillins • Ureidopenicillins 15
Aminopenicillins
• Agents – Ampicillin (Omnipen ® , Principen ® ) – Amoxicillin (Amoxil ® , Trimox ® ) – Bacampicillin (Spectrobid ® ) • Broader spectrum over penicillin – Gram {-} aerobes – Listeria monocytogenes – Proteus mirabilis – E. coli 16
Carboxypenicillins
• Agents – Carbenicillin (Geopen®) – Ticarcillin (Ticar®) • More coverage than the aminopenicillins – Increased Gram {-} coverage – Peudeomonas aeruginosa • Ticarcillin 2-4× > Carbenicillin – Enterobacter • Carbenicillin concentrates rapidly in urine 17
Ureidopenicillins
• Agents – Azlocillin (Azlin ® ) • Discontinued in the US – Mezlocillin (Mezlin ® ) – Pipercillin (Pipracil ® ) • Activity – Maintains Gram {+} coverage – Added Gram {-} – Anti-pseudomonal activity 18
β-Lactamase Inhibitors
• Chemicals with no antibacterial activity that irreversibly inactivate β-lactamase – Sulbactam • With ampicillin (Unasyn ® ) – Tazobactam • With pipercillin (Zosyn ® ) – Clavulanate/Clavulanic acid • With amoxicillin (Augmentin ® ) • With ticarcillin (Timentin ® ) 19
Cephalosporins
• Spectra of activity (generation) • Anaerobic activity (Cephamycins) • Anti-pseudomonal activity • Methyltetrazolethiomethyl side-chain • Metabolism/elimination • Cerebrospinal fluid penetrance 20
1
st
Generation Agents
• Cefazolin (Ancef ® , Kefzol ® ) • Cefadroxil (Duricef • Cephalexin (Keflex • Cephalothin (Keflin • Cephapirin (Cefadyl ® • Cephradine (Anspor ® ® ® ) ® ) ) ) – Cephalosporin analog of amoxicillin – Cephalosporin analog of ampicillin , Velosef ® ) 21
1
st
Generation Cephalosporins
• Great Gram {+} activity • No activity against enterococci or
Listeria monocytogenes
• Mainstay of choice for uncomplicated community acquired infections • PEcK activity – Proteus – E. coli – Klebsiella 22
2
nd
Generation Agents
• Cefaclor (Ceclor ® ) • Cefamandole (Mandol ® ) • Cefmetazole (Zefazone ® ) • Cefoxitin (Mefoxin ® ) • Cefotetan (Cefotan ® ) • Cefonicid (Monocid ® ) • Cefprozil (Cefzil ® ) • Cefuroxime (Ceftin ® , Zinacef ® , Kefurox ® ) 23
2
nd
Generation Cephalosporins
• More Gram {-} activity than 1 st generation agents • Often used for UTIs and URIs • HENPEcK activity – H. influenzae – Enterobacter * (rapid resistance occurs) – Neisseria – Proteus – E. coli – Klebsiella 24
3
rd
Generation Agents
• Cefdinir (Omnicef ® ) • Cefditoren (Spectracef ® ) • Cefixime (Suprax ® ) • Cefoperazone (Cefobid ® ) • Cefotaxime (Claforan ® ) • Cefpodoxime (Vantin ® ) • Ceftazidime (Fortaz ® , Tazidime ® ) • Ceftibuten (Cedax ® ) • Ceftizoxime (Cefizox ® ) • Ceftriaxone (Rocephin ® ) 25
3
rd
Generation Cephalosporins
• Have even better Gram {-} coverage than second generation agents • Loses more Gram {+} coverage • Extra coverage against Serratia and
Moraxella catarrhalis
26
4
th
Generation Cephalosporins
• Cefepime (Maxipime Gram {+} coverage – No anaerobic activity ® ) – Has most of the Gram {-} coverage with – Anti-pseudomonal activity 27
The Generation Progression
• As one moves up in cephalosporin generation, more Gram {-} activity is seen • Consequently, Gram {+} activity is decreased advancing in generation • 4 th generation has Gram {-} activity without sacrificing Gram {+} activity 28
Keeping Generations Straight
• How can one keep them all straight?
• 1 st generation: – If the “f” sound is spelled “ph”, it HAS to be a 1 st generation (phirst) • 3 rd generation: – If an “f” is followed immediately by a “d” or “t”, it HAS to be a 3 rd generation (third) • 4 th generation: – “Cefepime is supreme!” 29
Cephamycins
• Cephamycins are a special subset of 2 anaerobic activity – Cefotetan – Cefoxitin • Mnemonic: Get a foxy tan on your back!
bacteria nd generation cephalosporins with great – Back is for bacteroides, a common anaeobic 30
Anti-Pseudomonal Cephalosporins
• 3 rd Generation – Cefoperazone – Ceftazidime • 4 th Generation – Cefepime • The 3 rd generation anti-pseduomonal agents lose even more Gram {+} activity than other 3 rd generation agents 31
MTT Side-Chain
• Methyltetrazolethiomethyl (MTT) – Hypoprothrombinemia and bleeding by disturbing synthesis of vitamin K dependent clotting factors • Risk factors are renal or hepatic disease, poor nutrition, the elderly, and cancer – Disulfiram-like reaction • Disulfiram is an agent that inhibits alcohol dehydrogenase, causing an increase of acetaldehyde, the agent that causes hangovers 32
MTT-Containing Cephalosporins
• Agents – Cefamandole – Cefmetazole – Cefoperazone – Cefotetan • Mnemonic: I met a man with a perfect tan 33
Cephalosporin Elimination
• For the most part, all are renal with few exceptions • The “zones” are hepatic – Cefoperazone – Ceftriaxone 34
CSF penetrance
• 2 nd Generation – Cefuroxime • Generally not used due to decreased efficacy • 3 rd Generation – Cefotaxime • Q6-8° dosing • Agent of choice in neonatal meningitis (along with ampicillin) – Ceftriaxone • Q12-24° dosing • Agent of choice for adult meningitis • Causes kernicterus in neonates 35
Monobactams
• Aztreonam (Azactam • Activity – Only Gram {-} ® ) • Resistant to most Gram {-} β-lactamases coverage (spectrum resembles aminoglycosides) – Excellent activity against P. aeruginosa – Superb Enterobacteriaceae activity – No Gram {+} or anaerobic activity 36
Carbapenems
• More resistant to hydrolysis from β lactamases • Very broad spectrum with coverage of Gram {+} (not MRSA), Gram {-}, anaerobes, and Pseudomonas aeruginosa • Higher incidence of seizure than other β-lactam agents 37
Carbapenem Agents
• Agents – Ertapenem (Invanz®) – Imipenem (Primaxin®) – Meropenem (Merrem®) • Ertapenem lacks coverage
Pseudomonas
acinetobacter, common nosocomial agents against two 38
Cilistatin
• Inhibits renal dehydropeptidase 1, an enzyme which degrades imipenem in the kidney brush border cells • Given only with imipenem (Primaxin effects nor antibacterial activity ® ) • Has neither β-lactamase inhibitory • Totally unrelated from the “statin” cholesterol drugs (HMG-CoA Inhibitors) 39
Glycopeptides
• Vancomycin (Vancocin ® ) • Teicoplanin (Targocid ® ) 40
Vancomycin
• Vancomycin makes five hydrogen bonds to the D-Ala-D-Ala amino acids at the end of the peptide cross-bridges • It prevents them from being accessible to the active site of the transpeptidases (where the β-lactams work) 41
Vancomycin Spectrum
• Gram {+} aerobes • MRSA • Penicillin-resistant pneumococcus 42
Vancomycin SE
• Renal clearance – Ototoxicity – Nephrotoxicity • These are points of contention as they are normally seen in conjunction with aminoglycosides…is it the aminoglycoside, or additive effect?
• Infusion related reactions: – “Red Man Syndrome” – Fever/chills – Phlebitis 43
VRE
• Vancomycin Resistant Enterococcus • Few options left: – Quinopristin/Dalfopristin (Sinercid none against Enterococcus faecalis treat – Linezolid (Zyvox ® ) • Covers both faecium and faeacalis ® ) • Coverage only against Enterococcus faecium, • Tip: Faecalis has a “hard c”, so it is harder to 44
Folic Acid Synthesis Inhibitors
45
Folic Acid Inhibitors
• “Sulfas” – Inhibit dihydropteroate synthetase, an enzyme involved in the synthesis of bacterial folic acid • Trimethoprim – Inhibit dihydrofolate reductase, an enzyme necessary for thymidine synthesis • Both are bacteriostatic 46
Folic Acid Inhibitor Spectrum
• Enterobacter • Chlamydia • Nocardia • Pneumocystis carnii 47
Folic Acid Inhibitor SE
• Rashes – Stevens-Johnson syndrome • Angioedema • Hemolytic anemia • Nephrotoxicity – Via precipitation of crystals of the inactive metabolite • Crosses the placenta – Kernicturus – Should be avoided in pregnancy and in children under 2 months of age 48
Nucleic Acid Synthesis Inhibitors
49
Nucleic Acid Inhibitors
• Fluoroquinolones 50
Fluoroquinolones
• Inhibit DNA topoisomerase II (DNA gyrase) • Bacteriostatic • Divided into generations; reverse of the reverse of cepholosporins Gram {-} activity, but loses Gram {+} Gram {+} activity, but retains Gram {-} (actual classification varies between sources) – Cephalosporins progress from Gram {+} to – Fluoroquinolones progress from Gram {-} to 51
1
st
Generation FQs
• Nalidixic Acid (NegGram ® ) • Gram {-} coverage only – Enterobacteraceae – E. Coli – Klebsiella – Proteus 52
2
nd
Generation FQs
• Agents – Cinoxacin (Cinobac ® ) – Enoxacin (Penetrex ® ) • Pulled from market – Lomefloxacin (Maxaquin ® ) – Norfloxacin (Noroxin ® ) • Increased Gram {-} spectrum 53
Advanced 2
nd
Generation FQs
• Agents – Ciprofloxacin (Cipro ® ) – Ofloxacin (Floxin ® ) • Has increased Gram {-} coverage along with atypicals • Cipro has good Pseudomonas coverage 54
3
rd
Generation FQ Agents
• Agents – Gatifloxacin (Tequin ® ) – Grepafloxacin (Raxar ® ) • Pulled from market – Levofloxacin (Levaquin ® ) • L -isomer of Ofloxacin – Sparfloxacin (Zagam ® ) – Temafloxacin (Omniflox ® ) • Pulled from market • Same coverage as 2 nd generation with moderate Gram {+} activity • Used in community acuquired pneumonia 55
4
th
Generation FQ Agents
• Agents – Alatrofloxacin (Trovan • Limited market availability d/t toxicity – Gemifloxacin (Factive – Moxifloxacin (Avelox – Trovafloxacin (Trovan ® ® ) ® ® ) IV) PO) • Limited market availability d/t toxicity • Same as 3 coverage rd generation with anaerobic 56
FQ Side Effects
• Complexes with cations • Photosensitivity • CYP450 interactions • Renal elimination • QT prolongation
Torsades de Pointes
• Hepatic failure (Trovan ® ) • Tendon rupture – Do not give if <18yo 57
Ribosomal Inhibitors
58
Anti-Ribosomal Agents
• Ribosomal Subunits – 30s Subunit (Prokaryotic)≈40s (Eukaryotic) • Tetracyclines • Aminoglycosides – 50s Subunit (Prokaryotic)≈60s (Eukaryotic) • Macrolides • Lincomycins • Chloramphenicol • Miscellaneous – Streptogramins – Oxazolidinones 59
Anti-Ribosomal Mnemonic
• Mnemonic: – @30, Amina cycles • (Aminoglycocide & Tetracycline) – @50, Mac likes Nicole • (Macrolide & Lincomycin & Chloramphenicol) • Hey, they’re cheesy, but I’m desperate for ideas!
60
30s Inhibitors
• Tetracyclines: – Bind to amino acyl t-RNA portion of the mRNA-ribosome complex – Bacteriostatic • Aminoglycosides – Bind to the separated 30s subunit causing misreading – Bacteriocidal 61
Tetracyclines
• Demeclocycline (Declomycin ® ) • Doxycycline (Vibramycin ® ) • Minocycline (Minocin ® ) • Tetracycline (Sumycin ® ) 62
Tetracycline Spectrum
• Gram {+} Bacilli • Gram {-} Rods • Gram {-} Bacilli – H. influenzae, Vibrio cholera • Spirochetes – Borrelia burgdorferi (Lyme dz), treponema pallidum (syphilis) • Chlamydia • Rickettsia rickettsii (Rocky Mt. Spotted Fever) 63
Tetracycline SE
• Chelates with cations – Decreased absorption with dairy, calcium – Deposition on calcified tissues • GI upset • Phototoxicity • Demeclocycline – Never used as an antibiotic because it can induce nephrogenic diabetes insipidus – Used in treatment of SIADH 64
Aminoglycocides
• Amikacin (Amikin ® ) • Gentamicin (Garamycin ® ) • Netilmycin (Netromycin ® ) • Neomycin (Mycifradin ® ) • Kanamycin (Kantrex ® ) • Streptomycin • Tobramycin (Nebcin ® ) 65
Aminoglycocide Spectrum
• Gram {-} Bacteria – Pseudomonas aeruginosa – Vibrio cholerae – Yersinia pestis (PLAGUE!
– Enterobacter aerogenes – E. coli – Klebsiella pneumoneae – Proteus – Serratia ) 66
Aminoglycocide SE
• Highly polar (cationic) molecules, usually prevents GI absorption • Renally eliminated – Ototoxicity – Nephrotoxicity • Neomycin-used topically, orally for hepatic failure • Streptomycin-used in TB 67
50s Inhibitors
• All 50s inhibitors binds irreversibly to 50s subunit, inhibiting translocation (peptidyl transferase – Therefore, giving ≥2 of these agents is redundant • Generally bacteriostatic (cidal @ high doses) 68
Macrolides
• Azalides: – Azithromycin (Zithromax ® ) • Ketolides: – Telithromycin (Ketek ® ) • Macrolides: – Clarithromycin (Biaxin ® ) – Dirithromycin (Dynabac ® ) – Erythromycin (Ery-Tab ® ) 69
Macrolide Spectrum
• Chlamydia (Erythro drug of choice in pregnancy) • Mycoplasma pneumoniae – Ureaplasma urealyticum • Legionella pneumophila • Treponema pallidum (Syphillis) • Gram (+) cocci • Gram (+) bacilli 70
Macrolide Spectrum
• Clarithro>erythro – Chlamydia, Legionella, Ureaplasma H. flu • Azithro
Macrolide SE
• Erythro destroyed by gastric acid – Enteric coated or esterified forms • Azithro concentrates in neutrophils, macrophages, fibroblasts • Erythro Azithro=hepatic; clarithro=renal • SE: – NVD, cholestatic jaundice (estolate salt erythro), Erythro & clarithro go through CYP450 72
Lincomycins
• Clindamycin (Cleocin ® ) • Lincomycin (Lincocin ® ) 73
Lincomycin Spectrum
• Gram {+} aerobes • Gram {+} anaerobes • Gram {-} anaerobes • NO gram {-} aerobic coverage • Think of these as 2 nd -line penicillins 74
Lincomycin SE
• Rash • Neutropenia • Thrombocytopenia • Erythema multiforme (rare) • Pseudomembranous colitis 75
Chloramphenicol
• Broad spectrum against Gram {+}, Gram {-}, and anaerobes.
• Can be extremely toxic – Dose-related revesible anemia – Hemolytic anemia in G6PD deficiency – Dose-independent aplastic anemia – “Grey baby syndrome” caused by drug accumulation leading to cyanosis, cardiovascular collapse and eventual death 76
Streptogramins
• Quinupristin/Dalfopristin (Synercid synthesis synthesis faecium (NO coverage ® ) – Dalfopristin inhibits early phase of protein – Quinupristin inhibits late phase of protein – Ratio 70% dalfopristin/30% quinupristin • Major use is for VRE Enterococcus against enterococcus faecalis) 77
Oxazolidinones
• Linezolid (Zyvox ® ) 78
Linezolid
• Linezolid binds to a site on the bacterial 23S ribosomal RNA of the 50S subunit and prevents the formation of a functional 70S initiation complex • Monoamine Oxidase Inhibition – Linezolid is a reversible, nonselective inhibitor of monoamine oxidase. Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents.
• Used in VRE and other severe infections 79
Cell Membrane Inhibitors
80
Cell Membrane Inhibitors
• Daptomycin (Cubicin ® ) • Unique mechanism of action that it binds to bacterial membranes and causes a rapid depolarization of membrane potential which leads to inhibition of protein, DNA, and RNA synthesis • Used in antibiotic resistant MRSA, VRE, and linezolid-resistant strains • Can cause myalgias 81
Take Home Messages
• Regarding mechanism of action: Know its major effect (cell wall vs. ribosomal) • Regarding side effects: Know what will kill (or maim) a person, or something totally unique to that drug • Regarding coverage: Know broad classes (Gram, anaerobic) • Regarding drugs: You will NEVER know everything about pharmacology, so don’t try to!
82
The End
83